SN

Sienna Biopharmaceuticals IncOOTC SNNAQ Stock Report

Last reporting period 30 Sep, 2019

Updated 02 Aug, 2023

Last price

Market cap $B

0

Micro

Exchange

OOTC - OTC

View Section: Price ratios

Sienna Statements

SN

Data from Sienna`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency :

USD - US dollar

Last reporting period :

30 Sep, 2019

New report :

Reporting period :

Quarterly

Earnings release date:

Expected release date:

Sienna Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

USD (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2019-09-30
%

100

0

0

3.82

0

5.021

0

8.841

14.4 %

0

-8.841

-14.4 %

0

0

-0.549

0

-8.588

-3.9 %

0

-4.618

0

-3.97

52 %

0

-0.129

30.726

2019-06-30
%

100

0

0

5.084

0

2.643

0

7.727

-51.2 %

0

-7.727

51.2 %

0

0

-0.537

0

-8.264

49.6 %

0

0

-8.264

49.6 %

0

-0.272

30.354

2019-03-31
%

100

0

0

7.093

0

8.746

0

15.839

-19.9 %

0

-15.839

19.9 %

0

0

-0.543

0

-16.382

15.3 %

0

0

-16.382

15.3 %

0

-0.666

24.606

2018-12-31
%

100

0

0

10.773

0

8.996

0

19.769

19.2 %

0

-19.769

-19.2 %

0

0

0.434

0

-19.335

-15.1 %

0

0

-19.335

-15.1 %

0

-0.929

20.807

2018-09-30
%

100

0

0

12.146

0

4.438

0

16.584

0

-16.584

0

0

-0.21

0

-16.794

0

0

-16.794

0

-0.82

20.473

View Section: Balance Sheet